TGM2 and colorectal carcinoma: Most of the analytes chosen (L1CAM, CA9, MSLN, MDK, HPN, KLK6, TGM2, ALGH1A1, EpCAM, and CD44) have not been studied previously as biomarkers in early detection of CRC.